Target
Mitogen-activated protein kinase 1 [8-360]
Ligand
BDBM193412
Substrate
n/a
Meas. Tech.
ERK-2 Enzymatic Assay
pH
7.3±n/a
IC50
0.90±n/a nM
Comments
extracted
Citation
 Blake, JFCook, AGaudino, JGunawardana, IWHicken, EJHunt, KWLyon, MMetcalf, ATMohr, PJMoreno, DANewhouse, BRen, LSchwarz, JChen, HGazzard, LSchmidt, JDo, S Serine/threonine kinase inhibitors US Patent  US9670208 Publication Date 6/6/2017 
Target
Name:
Mitogen-activated protein kinase 1 [8-360]
Synonyms:
ERK2 | Human ERK-2 | MAPK1 | MK01_HUMAN | Mitogen Activated Kinase 1 | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (aa 8-360) | PRKM1 | PRKM2
Type:
n/a
Mol. Mass.:
40835.09
Organism:
Homo sapiens (Human)
Description:
P28482 aa 8-360
Residue:
353
Sequence:
GAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
  
Inhibitor
Name:
BDBM193412
Synonyms:
US9670208, Example 276 N-(1-methyl-1H-pyrazol-5-yl)-4-(3-((4-methylpyridin-2-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl)pyrimidin-2-amine
Type:
Small organic molecule
Emp. Form.:
C21H19N9
Mol. Mass.:
397.4359
SMILES:
Cc1ccnc(Cc2nnc3cc(ccn23)-c2ccnc(Nc3ccnn3C)n2)c1
Structure:
Search PDB for entries with ligand similarity: